Institutional shares held 157 Million
1.43M calls
2.3M puts
Total value of holdings $7.52B
$68.7M calls
$111M puts
Market Cap $9.1B
176,960,000 Shares Out.
Institutional ownership 88.54%
# of Institutions 651


Latest Institutional Activity in EXAS

Top Purchases

Q2 2025
Massachusetts Financial Services CO Shares Held: 2.97M ($153M)
Q2 2025
Goldman Sachs Group Inc Shares Held: 2.21M ($114M)
Q2 2025
Holocene Advisors, LP Shares Held: 2.15M ($110M)
Q2 2025
Norges Bank Shares Held: 910K ($46.8M)
Q2 2025
Readystate Asset Management LP Shares Held: 900K ($46.3M)

Top Sells

Q2 2025
Price T Rowe Associates Inc Shares Held: 3.7M ($190M)
Q2 2025
T. Rowe Price Investment Management, Inc. Shares Held: 322K ($16.6M)
Q2 2025
State Street Corp Shares Held: 5.38M ($277M)
Q2 2025
Ubs Asset Management Americas Inc Shares Held: 1.91M ($98.2M)
Q2 2025
Ameriprise Financial Inc Shares Held: 2.22M ($114M)

About EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.


Insider Transactions at EXAS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
378K Shares
From 22 Insiders
Grant, award, or other acquisition 138K shares
Exercise of conversion of derivative security 220K shares
Open market or private purchase 19.5K shares
Sell / Disposition
156K Shares
From 11 Insiders
Payment of exercise price or tax liability 149K shares
Open market or private sale 6.55K shares
Bona fide gift 1.06K shares

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS